Interventional Study To Evaluate The Effect Of An Ayurvedic Tablet, Cream And Purgative Therapy On The Participants Of Psoriasis(Skin Condition)
Phase 2
- Conditions
- Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2024/05/067843
- Lead Sponsor
- O SPONSER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Children of either sex in between age group of 10 to 16 years.
2.Patients presenting with clinical features of psoriasis.
3.Mild to Moderate psoriasis in affected area according to PASI Scale (1-69%)
4.Patient should be capable of obeying the instruction related to course of therapy
Exclusion Criteria
1.Severe psoriasis in affected area according to PASI scale. (more than 70%)
2.Known case of Acute/Chronic Eczema and Leprosy.
3.Development of any allergic or hypersensitive signs and symptoms during the trial period (due to trialdrug).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Change in the scoring/grading of symptom of psoriasis in PASI scaleTimepoint: 4 MONTHS
- Secondary Outcome Measures
Name Time Method 1.Change in the APso-QOL parameter <br/ ><br>2.To evaluate the safety of trial drug (Khadira- Triphaladi Kasaya Ghanvati and Aragvadha Cream) <br/ ><br>Timepoint: 4 months